BMRN vs TELA · P/E 40, rev $1.76B vs rev $38.4M
Biomarin Pharmaceutical Inc (BMRN) versus Tela Bio Inc (TELA) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Tela Bio Inc (TELA) is a medical devices company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported TELA revenue for 2026-06-30 was $38.4M. Net income was -$23.5M. TELA currently screens at market cap $38.5M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. TELA currently screens at market cap $38.5M.
Not investment advice. Open the BMRN and TELA stock pages for the full models.
Not investment advice.